MAIA Biotechnology, Inc. (MAIA)

USD 1.94

(-11.82%)

Net Debt Summary of MAIA Biotechnology, Inc.

  • MAIA Biotechnology, Inc.'s latest annual net debt in 2023 was -7.15 Million USD , up 34.7% from previous year.
  • MAIA Biotechnology, Inc.'s latest quarterly net debt in 2024 Q2 was -11.57 Million USD , down -39.99% from previous quarter.
  • MAIA Biotechnology, Inc. reported annual net debt of -10.95 Million USD in 2022, down -3.56% from previous year.
  • MAIA Biotechnology, Inc. reported annual net debt of -10.57 Million USD in 2021, down -5195.01% from previous year.
  • MAIA Biotechnology, Inc. reported quarterly net debt of -11.57 Million USD for 2024 Q2, down -39.99% from previous quarter.
  • MAIA Biotechnology, Inc. reported quarterly net debt of -9.14 Million USD for 2023 Q2, down -20.56% from previous quarter.

Annual Net Debt Chart of MAIA Biotechnology, Inc. (2023 - 2019)

Historical Annual Net Debt of MAIA Biotechnology, Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -7.15 Million USD 34.7%
2022 -10.95 Million USD -3.56%
2021 -10.57 Million USD -5195.01%
2020 -199.7 Thousand USD 88.07%
2019 -1.67 Million USD 0.0%

Peer Net Debt Comparison of MAIA Biotechnology, Inc.

Name Net Debt Net Debt Difference
AIM ImmunoTech Inc. -4.94 Million USD -44.634%
Ampio Pharmaceuticals, Inc. -3.81 Million USD -87.436%
Armata Pharmaceuticals, Inc. 106.84 Million USD 106.692%
Actinium Pharmaceuticals, Inc. -74.56 Million USD 90.41%
Azitra, Inc. -910.04 Thousand USD -685.754%
Can-Fite BioPharma Ltd. -4.23 Million USD -68.728%
Chromocell Therapeutics Corporation 1.17 Million USD 709.975%
Calidi Biotherapeutics, Inc. 5.18 Million USD 237.858%
CEL-SCI Corporation 9.42 Million USD 175.861%
iBio, Inc. -9.75 Million USD 26.66%
Lineage Cell Therapeutics, Inc. -32.49 Million USD 77.991%
Matinas BioPharma Holdings, Inc. -1.28 Million USD -458.212%
Navidea Biopharmaceuticals, Inc. 438.44 Thousand USD 1730.926%
NovaBay Pharmaceuticals, Inc. -390 Thousand USD -1733.512%
NanoViricides, Inc. -4.79 Million USD -49.042%
Oragenics, Inc. -3.17 Million USD -125.517%
BiomX Inc. -772 Thousand USD -826.256%
BiomX Inc. -772 Thousand USD -826.256%
Protalix BioTherapeutics, Inc. 2.64 Million USD 370.143%
Palatin Technologies, Inc. -8.93 Million USD 19.988%
Scorpius Holdings, Inc. 13.85 Million USD 151.603%